Skip to main content

Month: August 2023

Avance Gas Holding Ltd: Key information relating to the dividend for the second quarter 2023

Bermuda, August 30, 2023 Key information relating to the dividend to be paid by Avance Gas Holding Ltd. for the second quarter 2023: Dividend amount: $0.50 Declared currency: USD Last day including right: September 6, 2023 Ex-date: September 7, 2023 Record date: September 8, 2023 Payment date: September 13, 2023 Date of Approval: August 29, 2023 For further queries, please contact: Randi Navdal Bekkelund, CFOEmail: IR@avancegas.comTel: +47 23 11 40 00 ABOUT AVANCE GASAvance Gas operates in the global market for transportation of liquefied petroleum gas (LPG). The Company is one of the world’s leading owners and operators of very large gas carriers (VLGCs) and operates a fleet of fourteen modern ships including two dual fuel LPG newbuildings for delivery in early 2024. For more information about Avance Gas, please visit www.avancegas.com. This...

Continue reading

Avance Gas Holding Ltd: Second Quarter 2023 Earnings Release

BERMUDA, August 30, 2023 – Avance Gas Holding Ltd (OSE: AGAS) (“Avance Gas” or the “Company”) today reports unaudited results for the second quarter 2023. HIGHLIGHTSThe average time charter equivalent (TCE) rate on load to discharge basis was $52,000/day compared to $58,400/day for the first quarter 2023, ahead of guidance of ~$50,000/day. The TCE basis discharge-to-discharge was $50,800/day also slightly ahead of guidance of ~$50,000/day. For the second quarter, we had a TC coverage of 41% at an average TCE rate of $40,000/day and spot voyages of 59% at $64,500/day. Freight hedging by use of FFA resulted in a loss of $2,500/day for the fleet. Daily operating expenses (OPEX) were $8,000/day, compared to $8,600/day for the first quarter of 2023. Net profit of $35.7 million compared to $36.3 million for the first quarter 2023, or earnings...

Continue reading

Cancer Diagnostic Market to Worth USD 276.8 Billion by 2030 | Skyquest Technology

Cancer diagnostic market is segmented by test, technology, application, end user and product. Based on the test, the cancer diagnostics market is segmented into instrument-based tests, laboratory tests, and liquid biopsies. Based on the application, the cancer diagnostics market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach, liver, esophagus, thyroid, pancreatic cancer, leukemia, and others. Based on the technology, the cancer diagnostics market is bifurcated into platform-based and instrument-based. By test, the market is segmented into hospitals, diagnostic laboratories, and others. Based on product, the cancer diagnostics market is segmented into consumables and instruments- Industry forecast 2023-2030 Westford, USA, Aug. 29, 2023 (GLOBE NEWSWIRE) — According to SkyQuest, the growth...

Continue reading

Razor Energy Corp. Announces Second Quarter Results

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW. CALGARY, Alberta, Aug. 29, 2023 (GLOBE NEWSWIRE) — Razor Energy Corp. (“Razor” or the “Company”) (TSXV: RZE) announces its second quarter financial and operating results. Selected financial and operational information is outlined below and should be read in conjunction with Razor’s unaudited interim condensed consolidated financial statements, management’s discussion and analysis for the three and six months ended June 30, 2023 which are available on SEDAR at www.sedar.com and the Company’s website www.razor-energy.com. All amounts are expressed in Canadian dollars. Certain metrics, including those expressed on an adjusted basis, are non-IFRS and other...

Continue reading

LSLPharma Group Announces Its Second Quarter Results

The Company continues to focus on increasing its revenues and production capacity43.5% revenue increase to $2.0 million Gross margin of 34%, up significantly from (23%) last year and 19% in the first quarter Adjusted EBITDA1 loss of $260,000 versus $1.4 million loss last year Shareholders’ equity of $10.5 million and net debt of $7.2 million at quarter endBOUCHERVILLE, Quebec, Aug. 29, 2023 (GLOBE NEWSWIRE) — Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced its financial results for the second quarter ended June 30, 2023. The Company’s Management’s Discussion and Analysis and unaudited consolidated financial statements are available on SEDAR. Unless otherwise specified, all amounts are in Canadian dollars. “We are pleased with these results...

Continue reading

iCoreConnect Provides Update on Post Business Combination Share Exchange

OCOEE, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – iCoreConnect, Inc. (Nasdaq: ICCT) (“iCore” or the “Company”), a cloud-based software and technology company focused on increasing workflow productivity and customer profitability through its enterprise and healthcare workflow platform, today provided an update on recent trading activity following the close of its business combination with FG Merger Corp. (“FGMC” (Nasdaq: FGMC), a special purpose acquisition corporation. Today, trading of ICCT’s securities was halted on Nasdaq when it was identified that certain shares did not convert using the post-business combination exchange ratio. The situation has been corrected and the Company will resume trading at market open on Wednesday, August 30, 2023. Shareholders seeking additional information on how this may impact their...

Continue reading

Smart Water Metering Market Set to Soar Past USD 16.51 Billion by 2030

The global Smart Water Metering market size is expected to reach USD 16.51 billion by 2030 and exhibit a CAGR of 10% in the forecast period (2023−2030), according to Skyquest’s latest research report. The increasing focus on water conservation and management, growing demand for accurate and real-time water consumption data, rising need for efficient water billing and revenue management systems, integration of smart water metering with smart city initiatives, aging water infrastructure and the need for leak detection and water loss prevention, are fueling the Market’s growth. Westford, USA, Aug. 29, 2023 (GLOBE NEWSWIRE) — According to SkyQuest’s latest global research of the Smart Water Metering market, adoption of advanced metering infrastructure (AMI) technology, integration of data analytics and artificial...

Continue reading

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

VANCOUVER, British Columbia, Aug. 29, 2023 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing, and promoting differentiated products, today reports financial results for the quarter ended June 30, 2023 (“Second Quarter 2023”) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency. Doug Janzen shares that “we are very optimistic with the launch of our newest product ZIMED® PF this month as we move into a new chapter for Aequus. The financial results from the first half of 2023 are during a transitional period that we anticipated to be lower, mainly driven by the conclusion of the Sandoz contract last year and a reduction in the prescription portion of our business....

Continue reading

Hydreight Announces Q2 2023 Financial Highlights

130% increase in total top-line non-GAAP Adjusted Revenue1 of C$4,416,103 for Q2 2023 over Q2 2022225% increase in total revenue of C$2,699,668 for Q2 2023 over Q2 2022VANCOUVER, B.C. and LAS VEGAS, Aug. 29, 2023 (GLOBE NEWSWIRE) — Hydreight Technologies Inc. (“Hydreight” or the “Company“) (TSXV: NURS)(FSE: SO6)(OTCQB: HYDTF), a fast-growing telehealth platform enabling flexible home healthcare, is pleased to announce the Company’s financial results for the three and six months ended June 30, 2023. The Company is pleased to report total top-line non-GAAP Adjusted Revenue1 of C$4,416,103 for Q2 2023, representing an increase of 130% compared to Q2 2022 Adjusted Revenue1 of C$1,922,339. “We are pleased to announce our sustained growth in the second quarter of 2023,” said Shane Madden, CEO of Hydreight....

Continue reading

HEMPSANA Announces Q2 and Year to Date 2023 Financial Results

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Aug. 29, 2023 (GLOBE NEWSWIRE) — Hempsana Holdings Ltd. (the “Company” or “Hempsana”) today announced financial results for the three and six months period ended June 30, 2023. Randy Ko, Hempsana’s CEO commented: “The investments we have made in our brands and brand partners to offer innovative products to the consumers is starting to bear fruit as we have seen significant revenue growth this quarter as seen in our results where we have increased our Q2 results from last year’s Q2 results by more than 50%. With over 20 SKUs being distributed across the nation, we will look to focus on increasing the market share of these products within their...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.